clinicaloptions.com/oncolog...?
-
This is an educational series intended for medical professionals, but patients that understand MedSpeak should be able to learn from it. It is sponsored by several organizations including the CLL Society.
-
In this CME/CE-certified activity, review the latest multidisciplinary strategies for optimizing care of patients with CLL, including discussion of effective patient education on treatment selection and toxicity management.
Discussion topics include:
• Evolving CLL Treatment Recommendations
• Individualizing Frontline Therapy for Patients With Chronic Lymphocytic Leukemia: Putting Evidence Into Practice
• Addressing Patient Knowledge Gaps, Concerns, and Misperceptions About CLL
• Assessing Measurable Residual Disease in Chronic Lymphocytic Leukemia
• Multidisciplinary Perspectives on Managing Adverse Events With BCL-2 and PI3K Inhibitors in CLL
• Multidisciplinary Perspectives on CLL-Related Symptoms and Managing Adverse Events With BTK Inhibitors
-
Len